drawing up semaglutide INJECTION Semaglutide Versus Ozempic - Invigorate
Description
The SELECT trial included participants with established cardiovascular disease, many in their 60s and 70s
Measurable weight loss typically becomes visible after four to six weeks of consistent use at the prescribed dose
Clothing fit changes noticeably by weeks 12-16
LC, locus ceruleus
Maintaining weight loss depends on lifestyle choices and long-term support
Possibly adding a new entrant to the highly competitive diabetes/weight loss market, Roche has announced positive interim results from an ongoing Phase I trial for its oral small molecule GLP-1 receptor agonist, CT996
